European Safety Registry in Ulcerative Colitis (P04808)
Ulcerative Colitis European Registry: A Prospective, Observational, Non-interventional, Post-Marketing Safety Surveillance Program
Sponsor: Centocor, Inc.
A observational or N/A phase clinical study on Ulcerative Colitis, this trial is completed. The trial is conducted by Centocor, Inc. and has accumulated 10 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2022 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Jun 2022 [monthly]
Completed
-
Sep 2018 — Jan 2021 [monthly]
Completed
▶ Show 5 earlier versions
-
Aug 2018 — Sep 2018 [monthly]
Completed
-
Jun 2018 — Aug 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: PHASE4 → None
-
Feb 2017 — Apr 2018 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Jun 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centocor, Inc.
- Merck Sharp & Dohme LLC
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.